Your session is about to expire
← Back to Search
Fostemsavir for HIV
Study Summary
This trial will test whether adding the drug Fostemsavir to a stable HIV regimen can increase immunologic parameters in patients who never experience optimal CD4 T-cell count recovery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research protocol admit individuals who are of advanced age?
"This medical trial welcomes individuals from the age of consent to 65 years old."
Is there availability for potential participants in this experiment?
"Affirmative. Information published on clinicaltrials.gov reveals that this medical trial has been actively recruiting since May 1st 2022 and the most recent update was released on September 20th 2022. The study is seeking 50 patients from a single location for participation."
Am I able to register for this medical experiment?
"This investigation is recruiting 50 individuals with HIV-1 infection between the permissible ages of 18 and 65. Candidates should have a documented plasma HIV-1 RNA count lower than 50 c/mL, CD4+ T cell counts below 350 cells/mm3 during ARV treatment for at least 2 years, stable health insurance plans, must add FTR 600 mg twice daily to their existing antiretroviral regimen for 6 months or more before screening, and attend a minimum of two clinic visits within 12 months prior to being accepted into this trial."
How detrimental is the FTR+suppressive regimen to individuals?
"With Phase 4 trials complete, the safety of FTR+suppressive regimen was rated a 3 due to its approval status."
How many participants has this research enrolled thus far?
"Affirmative. The records available on clinicaltrials.gov verify that this research is actively recruiting subjects, having been posted on May 1st 2022 and updated most recently in September 20th of the same year. Approximately 50 people must be sourced from a single medical site."
Share this study with friends
Copy Link
Messenger